Metraipolis › archive › dc_770ec8522782
Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up — Europe PMC PMID:42078821
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42078821
- DOI
- 10.1016/j.rpth.2026.103405
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:05:31.461Z
- SHA-256 of the archived text
6217329ae056782ae3698900ddfaf0f063d8954ca26756aee043cbdf3f22f1f3- Stable URL of this page
https://metraipolis.com/documento/dc_770ec8522782
How to cite
Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up — Europe PMC PMID:42078821 — Europe PMC (en), https://europepmc.org/article/MED/42078821 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_770ec8522782 (Metraipolis archive dc_770ec8522782, sha256 6217329ae056782ae3698900ddfaf0f063d8954ca26756aee043cbdf3f22f1f3)
BibTeX
@misc{dc770ec8522782,
title = {Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up — Europe PMC PMID:42078821},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42078821},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_770ec8522782; sha256 6217329ae056782ae3698900ddfaf0f063d8954ca26756aee043cbdf3f22f1f3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42078821. Agents can read the archived copy with the MCP tool read_document.